Dartmouth researchers were awarded $15 million during March, including $9 million in new and competing awards. Among the recipients of recent new and competing grants, as reported by the Office of Sponsored Projects:
Brown University
" Cancer Assessments and Reports of End-of-Life Treatment"
3-Year Award
Cystic Fibrosis Foundation
" The Interaction of S. aureus with CFT-1 Cells"
2-Year Award
Avigen Incorporated
" Avigen Contract"
Health Resources and Services Administration
" Ryan White Care Act Title III Early Intervention Services (EIS) Program"
National Cancer Institute
" Develop a Primary Care Colon Cancer Screening Consortium"
2-Year Award
Ligand Pharmaceutical
" Phase I PK Evaluation of Targretin & Cis/Vin in Advanced NSCLC"
National Institute of General Medical Sciences
" Functional Analysis of a Model Filamentous Fungus (NIGMS Program Project)"
5-Year Award
National Institutes of Health
" Soluble Cargo Selection in COPII-Dependent ER-Export"
3-Year Award
National Safe Kids Campaign
" Safe Kids Initiative"
National Institute of Mental Health
" PTSD, Medical Utilization and Health in Primary Care"
National Heart, Lung, and Blood Institute
" Pharmacogenetics of the Human Prostacyclin Receptor"
4-Year Award
American International Health Alliance
" Reproductive Health Partnership in Kosovo"
New England Foundation for the Arts
" Cudamani"
and
" Axis Dance Company"
and
" Mark Morris Dance Group"
and
" Erin Orr - "Savage Nursery""
Amgen, Inc.
" Health Care Utilization & Costs Assoc w Anemia Correction"
National Science Foundation
" Research Experience for Undergraduate-Molecular and Cellular Biology"
3-Year Award
Hoffman La Roche
" Phase III Study of Intermittent Oral Capecitabine w/Combo IV Oxaplatin"
National Heart, Lung, and Blood Institute
" Endothelial Cell Regulation of Smooth Muscle Phenotype"
4-Year Award
National Inst. of Arthritis and Musculoskeletal and Skin Disease
" Autoimmunity/Connective Tissue Biology Training Program"
5-Year Award
National Heart, Lung, and Blood Institute
" Angiogenesis and Myocardial Ischemia"
4-Years
Eli Lilly and Company
" Prevention of Cancer in Rats by Raloxifene and Analogs"
Cystic Fibrosis Foundation
" RDP Developmental Grant (Cell Culture/Cell Biology Core)"
National Cancer Institute
" Atypical Nevi in Melanoma: A Case Control Study"
3-Year Award
National Institute of Diabetes and Digestive and Kidney Diseases
" Mapping the Mechanical Properties of the Diabetic Foot"
Department of Justice, National Institute of Justice
" The Institute for Security Studies at Dartmouth College"
Department of Justice, National Institute of Justice
" The Institute for Security Studies at Dartmouth College"
Department of Justice, National Institute of Justice
" The Institute for Security Studies at Dartmouth College"
Department of Justice, National Institute of Justice
" The Institute for Security Studies at Dartmouth College"
Award commitment from the sponsoring agency is for a single year unless otherwise indicated.